Scala Bio
Founded 2022 · 34 employees on LinkedIn · 3 known investors
Scala Biodesign develops computational protein design software (ScalaOS) that combines atomistic modeling, evolutionary data, and AI to optimize enzymes, antibodies, therapeutic proteins, and antigens in a single design round. It serves biotechnology and biopharmaceutical companies working on areas such as biocatalysts, biologics, and vaccines.
Founders & leadership
Scala Bio was founded in 2022 by Ravit Netzer and Adi Goldenzweig.
RN
Ravit NetzerCo-founder & CEO
AG
Adi GoldenzweigCo-founder & CTO
SF
Sarel FleishmanChief Scientist
Investors · 3
Frequently asked questions
- What does Scala Bio do?
- Scala Biodesign develops computational protein design software (ScalaOS) that combines atomistic modeling, evolutionary data, and AI to optimize enzymes, antibodies, therapeutic proteins, and antigens in a single design round. It serves biotechnology and biopharmaceutical companies working on areas such as biocatalysts, biologics, and vaccines.
- Who founded Scala Bio?
- Scala Bio was founded by Ravit Netzer, Adi Goldenzweig in 2022.
- Who are Scala Bio's investors?
- Scala Bio's investors include IT-Farm Corporation, TLV Partners, Deep Insight.